Damora Therapeutics, Inc. (DMRA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$18.56

From 52W high−43.56%

Volume292629.00

Market cap$1.19B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$18.56

From 52W high

−43.56%

Volume

292629.00

Market cap

$1.19B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.9x

P/E (TTM)

—

RSI (14)

38.5

MomentumView details →

1D Return

+4.50%

YTD Return

−15.43%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2.9x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−50.93%

ROA (TTM)

−48.35%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+4.50%

YTD Return

−15.43%

1Y Return

+106.37%

RSI (14)

38.5

vs 50D SMA

−22.88%

vs 200D SMA

−24.20%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

19.73x

Quick Ratio

19.73x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.39

EPS Surprise

5.79%

Beats (12Q)

1/12

Next Q EPS Est

−$0.51

Avg Surprise (4Q)

5.79%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−262.83M

Op. CF (TTM)

—

Next earningsNov 5, 2026 →

Latest newsMore news →

No recent news for DMRA.

Similar companies

Omeros CorporationOMER Kardigan, Inc.KARD Syndax Pharmaceuticals, Inc.SNDX Alpha Tau Medical Ltd.DRTS Silence Therapeutics plcSLN Bicara Therapeutics Inc. Common StockBCAX Find similar companies →

Latest newsMore news →

No recent news for DMRA.